Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2018

View Archived Issues

XW Laboratories initiates phase I study of XW-10172 for narcolepsy

Sosei regains rights to CGRP antagonist programs from Teva

Identification of novel locus for idiopathic dilated cardiomyopathy in African Americans

MB-66 vaginal film shows HIV, HSV neutralizing activity in phase I study

Patient enrollment begins in phase III study of favipiravir for thrombocytopenia syndrome

Reduced adverse effect potential demonstrated with Mebias Discovery's mu-opioid receptor agonists

Researchers present data on mRNA-based vaccine for HIV-1 infection

AbbVie gains rights to discovery programs from X-Chem

Bellicum Pharmaceuticals reports encouraging interim data from clinical trial of BPX-501

Shionogi launches Xofluza in Japan

Ideaya Biosciences, CRUK enter partnership to develop PARG inhibitors

Intra-Cellular Therapies plans rolling NDA submission for lumateperone

AbCellera Biologics receives DARPA contract for rapid countermeasures against viral outbreaks

Ardelyx divulges novel FXR agonists

Boehringer Ingelheim and Vanderbilt University expand cancer collaboration

New IDO1 inhibitors presented by InnoCare Pharma

Kadimastem cleared to conduct phase I/IIa study of ALS treatment

Second pivotal phase III study of AbbVie's elagolix meets primary endpoint

Escalier Biosciences closes series B financing

Protalix Biotherapeutics' OPRX-106 produces clinical response in study in ulcerative colitis

FDA accepts sBLA for Keytruda in advanced cervical cancer with priority review

Eight-week grazoprevir/elbasvir treatment shown effective against HCV infection

Phanes partners with Crown Bioscience to advance oncology drug discovery pipeline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...